Todos Medical Receives FDA Certificate of Free Sale for New 5-Day Tollovid Dosing Regimen
May 04, 2021 08:30 ET | Todos Medical Ltd.
Company sees this new dosing regimen of 60 pills over 5 days as optimal for Tollovid, the Company’s 3CL protease inhibitor botanical dietary supplement that helps to support and maintain healthy...
Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa Breast Cancer Blood Test
April 22, 2021 11:35 ET | Todos Medical Ltd.
 Todos plans to commercialize Videssa in late 2021 to reduce unnecessary biopsies in the $7.19 billion mammogram naïve market and integrate it into its TBIA Platform  Provista Diagnostics’ testing...
Todos Medical Launches Phase 2 Clinical Trial of Its Antiviral 3CL Protease Inhibitor NLC-V-01 (Tollovir) in Hospitalized COVID-19 Patients
April 19, 2021 10:30 ET | Todos Medical Ltd.
First 10 patients dosed in 77 patient randomized, double blind, placebo controlled Phase 2 Clinical Trial at Shaare Zedek Medical Center in Jerusalem, IsraelData from randomized, placebo controlled,...
Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application Covering Diagnosis of Cancer Using Proprietary Artificial Intelligence TBIA Immune Profiling Platform
April 08, 2021 09:27 ET | Todos Medical Ltd.
NEW YORK, NY, and REHOVAT, ISRAEL, April 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics solutions company, today announced...
Todos Medical Completes Automation Equipment Installation and Training for Meadowlands Diagnostics
April 01, 2021 07:00 ET | Todos Medical Ltd.
·       Minority-owned lab now well positioned to attract and expand institutional contracts with skilled nursing facilities, ambulatory surgery centers, schools & first responders ...
Todos Medical Enters Into Distribution Partnership with Osang Healthcare for the GeneFinder Plus™ COVID-19 Plus RealAMP Kit in the United States
March 30, 2021 09:23 ET | Todos Medical Ltd.
GeneFinder Plus has received Emergency Use Authorization from the US FDAAnalysis demonstrates GeneFinder Plus able to detect B.117, B.135, P1 and other variantsValidation ongoing with Saliva,...
Todos Medical Completes Automation Equipment Installation and Training for a Laboratory Client in Brooklyn, NY
March 29, 2021 07:20 ET | Todos Medical Ltd.
·       Automation solution increases processing capacity to 6,000 PCR tests per day, expandable to 12,000 daily tests with minor upgrades ·       Client entered into contract with the State of...
Todos Medical Enters Into Automation and Reagent Supply Agreement with MAJL Diagnostics
March 23, 2021 08:00 ET | Todos Medical Ltd.
NEW YORK, NY, REHOVAT, ISRAEL, and ATLANTA, GA, March 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing...
Todos Medical Provides Corporate Update
March 17, 2021 12:00 ET | Todos Medical Ltd.
PCR COVID lab sales strengthening as the US prepares to implement serial COVID testing programs to further re-open the economyScaling molecular lab business by deepening COVID offering and...
Todos Medical Announces $7.2M in Sales for February 2021, a 38% Month Over Month Increase From Sales of $5.2M in January 2021
March 12, 2021 09:39 ET | Todos Medical Ltd.
·       $12.5M in combined January 2021 and February 2021 sales ·       President Biden signs American Recovery Act into law NEW YORK, NY, REHOVAT, ISRAEL, March 12, 2021 (GLOBE NEWSWIRE) -- via...